Suchergebnisse - "Dyslipidemias"

PubPharm (14.100)

11

Description of the Effectiveness, Safety, Tolerability and Adherence to Amlodipine/Atorvastatin/Perindopril Single Pill Combination Treatment in Patients With Arterial Hypertension and Dyslipidemia (TARGET) : DescripTion of the Effectiveness, Safety, Tolerability and Adherence to Amlodipine/atoRvastatin/Perindopril sinGle Pill Combination trEatmenT in Patients With Arterial Hypertension and Dyslipidemia in the Daily Clinical Practice. (TARGET)

enthalten in: ClinicalTrials.gov | 2024

12

Hyperandrogenism and Cardiometabolic Risk in Pre- and Postmenopausal Women-What Is the Evidence?

enthalten in: The Journal of clinical endocrinology and metabolism | 2024

von Hirschberg, A.

13

The pharmacokinetics of single-dose oral atorvastatin and its metabolites support therapeutic use in cockatiels (Nymphicus hollandicus)

enthalten in: American journal of veterinary research | 2024

von Mitchell, M. | Guzman, D. | Knych, H. | +1

14

Carotenoid pattern intake and relation to metabolic status, risk and syndrome, and its components - divergent findings from the ORISCAV-LUX-2 survey

enthalten in: The British journal of nutrition | 2024

von Bouayed, J. | Vahid, F.

15

Study of ARO-ANG3 in Adults With Mixed Dyslipidemia : A Double-blind, Placebo-controlled Phase 2b Study to Evaluate the Efficacy and Safety of ARO-ANG3 in Adults With Mixed Dyslipidemia

enthalten in: ClinicalTrials.gov | 2024

16

Study of ARO-APOC3 in Adults With Mixed Dyslipidemia : A Double-Blind, Placebo-Controlled Phase 2b Study to Evaluate the Efficacy and Safety of ARO-APOC3 in Adults With Mixed Dyslipidemia

enthalten in: ClinicalTrials.gov | 2024

17

The Soy Treatment Evaluation for Metabolic Health (STEM) Trial : Role of Soy for Metabolic Health: The Soy Treatment Evaluation for Metabolic Health (STEM) Trial

enthalten in: ClinicalTrials.gov | 2024

18

A Study of LY3561774 in Participants With Mixed Dyslipidemia : A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study to Investigate the Efficacy and Safety of LY3561774 in Adults With Mixed Dyslipidemia

enthalten in: ClinicalTrials.gov | 2024

19

Efficacy and Safety of Inclisiran as Monotherapy in Chinese Adults With Low or Moderate ASCVD Risk and Elevated Low-density Lipoprotein Cholesterol. : A 6 Month Randomized, Double-blind, Placebo-controlled Study Followed by a 6 Month Open- Label Extension to Assess the Efficacy and Safety of Inclisiran as Monotherapy in Chinese Adults With Low or Moderate ASCVD Risk and Elevated Low-density Lipoprotein Cholesterol

enthalten in: ClinicalTrials.gov | 2024

20

Culturally Adapted Dietary Clinical Trial in PR : Culturally Adapted Dietary Clinical Trial in PR: Puerto Rico Evaluation of a Culturally Informed Sustainable Intervention for Optimal Nutrition (PRECISION)

enthalten in: ClinicalTrials.gov | 2024